Tapahtumakalenteri

kesäkuu 28

Dissertation: Moon Hee Lee

Moon Hee Lee, University of Helsinki, Faculty of Medicine, Translational immunology research program (TRIMM), Doctoral Program in Clinical Research
The immunological profile of renal cell carcinoma patients

Opponent: Docent Jussi Koivunen, University of Oulu and Oulu University Hospital



Aloitusaika: 28.06.2023 12:00
Lopetusaika: 28.06.2023 14:00
Kesto: 2 hours
Sijainti: Biomedicum1, lecture hall 2, Haartmaninkatu 8, 00290 Helsinki
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: moonhee.lee@helsinki.fi
heinäkuu 05

EVOMET Metastasis expansion and drug resistance workshop

​Featured talks by: 
Clare Isacke, ICR, London
Anna Obenauf, IMP, Vienna
Kari Alitalo, Uni. Helsinki
Anniina Färkkilä, Uni. Helsinki
Aleix Prat, IDIBAPS, Barcelona
Samra Turajlic, Francis Crick Institute, London

Host: Sakari Vanharanta



Aloitusaika: 05.07.2023 09:00
Lopetusaika: 05.07.2023 13:00
Kesto: 3 hours
Sijainti: Biomedicum1, lecture hall 2, Haartmaninkatu 8, 00290 Helsinki
Tyyppi: Workshop
Organisaatio: EVOMET
Yhteyshenkilö: sakari.vanharanta@helsinki.fi
elokuu 04

Dissertation: Pauliina Kallio

​Paulina Kallio: University of Helsinki, Faculty of Medicine, Doctoral Programme in Biomedicine
Analysis of transcription factor and growth factor vulnerabilities in tumor development and treatment resistance
Opponent: professor Curzio Rüegg, University of Fribourg


Aloitusaika: 04.08.2023 12:00
Lopetusaika: 04.08.2023 14:00
Kesto: 2 hours
Sijainti: Biomedicum1, lecture hall 3, Haartmaninkatu 8, 00290 Helsinki
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: pauliina.kallio@helsinki.fi
elokuu 10

TRIMM and iCAN seminar: Dr Lélia Delamarre

Director & Distinguished Scientist of Cancer Immunology at Genentech, San Francisco, Dr Lélia Delamarre will give a seminar on  


Cancer Vaccines: potential and challenges  


 

Lélia's laboratory is dedicated to investigate innovative methods for enhancing anti-tumor T cell responses through priming. Currently, their research has shifted towards identifying tumor antigens that influence immune responses to cancer. Dr. Delamarre's work has demonstrated that cancer-specific mutations, known as neo-antigens, which accumulate in tumors, possess high immunogenicity and can stimulate protective T cell responses against cancer. With the recent advancements in next-generation sequencing technologies, it has become possible to quickly and comprehensively discover cancer-specific mutations in individual patients. This presents an exciting opportunity to develop new strategies that specifically target neoantigens.

During her visit, Dr. Delamarre is also serving as Manlio Fusciello’s opponent on Friday 11th of August at 12:00 in Biocenter 2, Hall 2041 (Viikinkaari 5, Helsinki). The title of Fusciello’s dissertation is Cancer vaccines: anti-tumoral t cell therapy on demand and the public defence can be watched online via https://video.helsinki.fi/unitube/live-stream.html?room=l18

 

You are all welcome to both events! 

  

 

Manlio Fusciello and Vince Cerullo


Aloitusaika: 10.08.2023 12:00
Lopetusaika: 10.08.2023 13:00
Kesto:
Sijainti: Biomedicum1, lecture hall 3, Haartmaninkatu 8, 00290 Helsinki
Tyyppi: Seminar
Organisaatio: iCAN Flagship Team
Yhteyshenkilö: ican@helsinki.fi
elokuu 10

Special Seminar: Martin Korte

Neurodegeneration and Neuroinflammation: what the flu got to do with it


We have a great pleasure to welcome an outstanding guest speaker, prof. Martin Korte, Technische Universität Braunschweig, Germany, in our special seminar on Thursday August 10th at 15-16 am at BMH1, Kok 8-9. 

 

https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/neuroinflammation-and-neurodegeneration/martin-korte/



 

Here Martin tells about his work and this talk:

 

What are your approaches to understand the influence of infections and inflammations for the progression of neurodegenerative diseases?

We use mice as a model system and approach our questions with cell biological, electrophysiological, imaging techniques and a behavioral analysis. We use influenca viruses of different strains to study long lasting effects of immune response in the brain (which is related to long/post covid).

 

How could an effective treatment look like in the future?

To prevent inflammatory processes inside the central nervous system might be an important step. But it could also well be that treatment is impossible, but that prevention is successful. Prevention could be life style factors, but also vaccination might be as important for our brains as it is for our immune system.

 

What will your talk be about?

The talk will cover common signaling mechanisms of the nervous-system and immune system. I will present data about the consequences of a sepsis for neurons in the central nervous system, the long-term effects in the CNS after an Influenza infection with different subtypes of the influenza virus and I will present data about the long-term consequences of maternal stress and early/late-life immune challenge in offspring


Aloitusaika: 10.08.2023 15:00
Lopetusaika: 10.08.2023 16:00
Kesto:
Sijainti: Biomedicum 1, meeting room 8-9
Tyyppi: Seminar
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: pirta.hotulainen@helsinki.fi